| AMPK | AMP-Activated Protein Kinase |
| ATP | Adenosine Triphosphate |
| BCL-2 | B-Cell Lymphoma 2 |
| CML | Chronic Myeloid Leukemia |
| CD38 | Cluster of Differentiation 38 |
| COX | Cyclooxygenase |
| DALY | Disability-Adjusted Life Year |
| DKD | Diabetic Kidney Disease |
| DNMT | DNA Methyltransferase |
| EPO | Erythropoietin |
| eNOS | Endothelial Nitric Oxide Synthase |
| FDA | Food and Drug Administration |
| G-CSF | Granulocyte Colony-Stimulating Factor |
| HALE | Healthy Life Expectancy |
| HDAC | Histone Deacetylase |
| HSP | Heat Shock Protein |
| IL | Interleukin |
| JAK | Janus Kinase |
| MDSC | Myeloid-Derived Suppressor Cell |
| MMP | Matrix Metalloproteinase |
| mTOR | Mechanistic Target of Rapamycin |
| mTORC1 | Mechanistic Target of Rapamycin Complex 1 |
| mTORC2 | Mechanistic Target of Rapamycin Complex 2 |
| NAM | Nicotinamide |
| NAD+ | Nicotinamide Adenine Dinucleotide |
| NADH | Nicotinamide Adenine Dinucleotide (Reduced Form) |
| NADase | Nicotinamide Adenine Dinucleotide Hydrolase |
| NAMPT | Nicotinamide Phosphoribosyltransferase |
| NF-κB | Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B cells |
| NK | Natural Killer (cell) |
| NMN | Nicotinamide Mononucleotide |
| NMNH | Reduced Nicotinamide Mononucleotide |
| NMNAT | Nicotinamide Mononucleotide Adenylyltransferase |
| NR | Nicotinamide Riboside |
| NRH | Dihydronicotinamide Riboside |
| NRK | Nicotinamide Riboside Kinase |
| NSAID | Non-Steroidal Anti-Inflammatory Drug |
| OSKM | Oct4, Sox2, Klf4, c-Myc |
| PARP | Poly(ADP-Ribose) Polymerase |
| PGC-1α | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha |
| PI3K | Phosphoinositide 3-Kinase |
| PKB/AKT | Protein Kinase B |
| RCT | Randomized Controlled Trial |
| ROS | Reactive Oxygen Species |
| SASP | Senescence-Associated Secretory Phenotype |
| SIRT | Sirtuin |
| SIRT1 | Sirtuin 1 |
| SkQ1 | 10-(6′-Plastoquinonyl)decyltriphenylphosphonium |
| STAC | Sirtuin-Activating Compound |
| TAME | Targeting Aging with Metformin (trial) |
| TNF-α | Tumor Necrosis Factor-alpha |
| TSC2 | Tuberous Sclerosis Complex 2 |
| ULK1 | Unc-51-like Kinase 1 |
| WHO | World Health Organization |